FDA Proposes New Approval Pathway for Ultra-Rare Disease Therapies

from The MAHA Report · host MAHA™ Action

U.S. Food and Drug Administration unveils new pathway to approve individualized therapies for ultra-rare genetic disease.

Episode metadata supplied by the publisher feed · Published Feb 26, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

FDA Proposes New Approval Pathway for Ultra-Rare Disease Therapies

0:00 6:55

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 6 minutes long.

This episode was published on February 26, 2026.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!